Subscribe Now Subscribe Today
Science Alert
 
FOLLOW US:     Facebook     Twitter
Blue
   
Curve Top
International Journal of Pharmacology
  Year: 2006 | Volume: 2 | Issue: 3 | Page No.: 293-297
DOI: 10.3923/ijp.2006.293.297
The Pharmacokinetics of Mitomycin C in the Mitomycin C, Ifosfamide and Cisplatin (MIC) Regimen
M.S. Highley, B. Harper , P.G. Harper , H. Dumez , G. Guetens , G. De Boeck , H. Prenen , D. Schrijvers , R.A.A. Maes and E.A. De Bruijn

Abstract:
The purpose of this study was to investigate the pharmacokinetics of mitomycin C when administered with ifosfamide and cisplatin as part of the mitomycin C, ifosfamide and cisplatin (MIC) regimen. Eleven patients with advanced non-small cell lung cancer, aged 49-73 years, were treated with mitomycin C (6 mg m-2), ifosfamide and cisplatin. Mitomycin C concentrations in plasma and erythrocytes were determined using HPLC with UV absorbance detection at 360 nm. The plasma β half life of mitomycin C was 44 min and the clearance 16.38 L h-1 m-2. A mean erythrocyte/plasma ratio of 0.87 (SD±0.35) was obtained. At low plasma concentrations, mitomycin C was undetectable in the erythrocyte. The mean plasma mitomycin C concentration when this occurred was 50 ng mL-1 (SD±35). The plasma pharmacokinetics of mitomycin C in the MIC regimen are consistent with the pharmacokinetic data obtained as a single agent, or as a component of other chemotherapy regimens. Mitomycin C is taken up into erythrocytes and is detectable within these cells for two hs following injection. The erythrocyte may act as a transporter of this compound in the circulation.
PDF Fulltext XML References Citation Report Citation
How to cite this article:

M.S. Highley, B. Harper , P.G. Harper , H. Dumez , G. Guetens , G. De Boeck , H. Prenen , D. Schrijvers , R.A.A. Maes and E.A. De Bruijn , 2006. The Pharmacokinetics of Mitomycin C in the Mitomycin C, Ifosfamide and Cisplatin (MIC) Regimen. International Journal of Pharmacology, 2: 293-297.

DOI: 10.3923/ijp.2006.293.297

URL: https://scialert.net/abstract/?doi=ijp.2006.293.297

 
COMMENT ON THIS PAPER
 
 
 

 

 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 
 
 
 

       

       

Curve Bottom